Benzinga · Oct 14, 2026
QUICK SPARK: Berkshire Stock Is Doing Something It Hasn’t Done Since January 2018
Berkshire Hathaway has risen 10 sessions in a row, its first such streak since January 2018 and the first under CEO Greg Abel.
NASDAQ · BRK
Healthcare · Medical - Equipment & Services
$0.08
Up+$0.00 (+2.69%)
Updated Oct 21, 2026, 7:42 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · BRK
1M range · 0 trading sessions · Daily adjusted prices
BRK does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning BRK.
Company
Market Activity
Research & News
BRK research
Company profile and research snapshot.
Bruker Corporation is a global developer, manufacturer, and distributor of high-performance scientific instruments and analytical and diagnostic solutions. The company provides advanced technologies for molecular and materials research, as well as for industrial and applied analysis.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Benzinga · Oct 14, 2026
Berkshire Hathaway has risen 10 sessions in a row, its first such streak since January 2018 and the first under CEO Greg Abel.
Benzinga · Oct 14, 2026
Bending Spoons stock surges 45% as Berkshire Hathaway invests another $330 million, raising its stake to 4% and backing future acquisitions.
Benzinga · Oct 13, 2026
Greg Abel sold off the entire position in Visa stock in Q1, once the 13th largest position in Berkshire’s investment portfolio.
Benzinga · Oct 12, 2026
Domino's Pizza stock has struggled in 2026. Did Warren Buffett's successor make the right move with the stock?
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning BRK.
No results
No recent SID articles mention BRK.